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Signiﬁcant advances have been made in developing microﬂuidic polymerase chain reaction (PCR) devices
in the last two decades. More recently, microﬂuidic microdroplet technology has been exploited to
perform PCR in droplets because of its unique features. For example, it can prevent crossover contami-
nation and PCR inhibition, is suitable for single-cell and single-molecule analyses, and has the potential
for system integration and automation. This review will therefore focus on recent developments on
droplet-based continuous-ﬂow microﬂuidic PCR, and the major research challenges. This paper will also
discuss a new way of on-chip ﬂow control and a rational design simulation tool, which are required to
underpin fully integrated and automated droplet-based microﬂuidic systems. We will conclude with a
scientiﬁc speculation of future autonomous scientiﬁc discoveries enabled by microﬂuidic microdroplet
technologies.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Contents
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Microﬂuidics has recently emerged as both a new technology
and a scientiﬁc research ﬁeld [1]. The early microﬂuidic device may
be traced back to 1970s when the microﬂuidic gas chromatography
was developed [2]. Since 1990s, microﬂuidics research and devel-
opment have accelerated, and have already demonstrated the po-
tential to revolutionise laboratory practice in chemistry and life
sciences. Themicroﬂuidic technology, also often calledMicro-Total-
Analysis Systems (mTAS), or Lab-on-a-Chip, can achieve common
laboratory functions on a small chip which can expedite biological/
chemical analyses, reduce the consumption of sample and reagents,
and thus provide creative and ingenious solutions to chemical,
pharmaceutical, healthcare and food industries [1].
The polymerase chain reaction (PCR) process was invented in
1984 by Kary Mullis, which has been used to amplify individual
deoxyribonucleic acid (DNA) segments for functional analysis of
genes in diseases. This simple chemical process has revolutionised
clinical diagnoses, and medical, biological and forensic analyses [3].
The early microﬂuidic PCR device was reported in 1993, where the
thermal cycles were performed in a continuous-single-phase-ﬂow
[4]. Since then, microﬂuidic PCR has been a research focus because
of its importance in life sciences, and there aremany review articles
devoted on this subject e.g. Refs. [5e8]. However, recent research
effort has been shifted to develop droplet-basedmicroﬂuidic PCR as
it can offer many advantages over single-phase operation and has
the most promising potential for system integration and automa-
tion [9]. In addition, droplet-based microﬂuidics is ideal for single-
cell and single-molecule analyses. However, some major research
challenges need to be tackled in order to enable fully integrated,
ﬂexible and automated droplet-based microﬂuidic systems. Here,
we will ﬁrst review the recent progresses in exploiting on-chip
microﬂuidic PCR in droplets, and then discuss how to develop in-
tegrated and automated droplet-based microﬂuidic systems. We
will concludewith our scientiﬁc speculation of a futuremicroﬂuidic
system capable of autonomous scientiﬁc discovery without (or
with minimal) human intervention.2. Microﬂuidic PCR in droplets
2.1. Single-phase microﬂuidic PCR
Contrary to the conventional PCR devices, microﬂuidic PCR has
small thermal mass, so thermal inertial effect may be negligible. In
addition, the large surface-to-volume ratio of microﬂuidic PCR
devices can ensure rapid heat transfer. Therefore, the time required
for samples to achieve equilibrium temperatures in thedenaturation and annealing steps can be signiﬁcantly reduced [10].
Because of rapid thermal response to the surrounding environ-
ment, the PCR mixtures are able to achieve more uniform tem-
peratures that will help to enhance the yield. Mixing can be rapid
even purely via diffusion, and consumption of expensive reagents is
dramatically reduced. Furthermore, pre and post PCR steps
including online sample handling, detection, mixing, and separa-
tion can be integrated into a single chip, which is essential for
system integration and automation [11e13].
However, in single-phase microﬂuidic PCR devices, PCR mixture
can be easily adsorbed at ﬂow channel surfaces, which causes PCR
inhibition and carryover contamination. The adsorption of biolog-
ical/chemical particles on surface is also enhanced by large surface/
volume ratio between channel surface area and sample volume,
and low ﬂow speed of PCR mixture adjacent to the surface.
Therefore, PCR inhibition and carryover contamination become a
serious problem for single-phase microﬂuidic PCR. Since PCR
mixture moves much faster in channel centre than close to surface,
the dwell times of PCR mixture in each thermal cycle are very
different, leading to reduced yield and increased overall processing
time. Furthermore, single-phase continuous-ﬂow microﬂuidic PCR
has the preference for amplifying short fragments and producing
short chimerical molecules [14]. These problems may be amenable
to microdroplet technology.2.2. Microﬂuidic PCR in droplets
Discrete droplets have been exploited in the conventional PCR
devices to provide a high throughput method for DNA sequencing
[14,15]. Droplet-based microﬂuidics utilises small volume droplets
as individual chemical reactors, which offer a well-controlled and
highly reproducible reaction condition. It has great potential to
transform the current practice in chemical and biological labora-
tories [16e18]. Massive parallelisation can be easily designed to
enhance throughput. Rapid advances have been made in micro-
droplet technology to generate droplets on-demand, and to
manipulate and detect droplets on-chip. Picolitre and even fem-
tolitre droplets have been demonstrated to perform single-cell and
single-molecule analyses [13]. The development of microdroplet
technology in general and its applications can be referred to the
recent review articles [15e20].
Since the very beginning, there has been strong research inter-
est in developing microﬂuidics technology to perform PCR in
droplets in order to beneﬁt from its small discrete volumes and
potential for automation [17]. Microdroplets provide an isolated
environment for chemical reactions, so PCR mixtures will not be in
direct contact with surface of ﬂow channels. Surface adsorption of
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vents microﬂuidic PCR inhibition and carryover contamination.
Although contamination may still occur during injection of PCR
mixtures into droplets, it can be prevented by using techniques
such as pico-injection method to add reagents to the droplets in a
sequential order as reported by Eastburn et al. [21].
It is well known that conventional PCR has a limited capacity
for amplifying larger DNA fragments and also suffers recombina-
tion between homologous gene fragments. In droplet-based
microﬂuidic PCR, the template fragments are contained in the
aqueous droplets, which encapsulate the target genes and are
immersed in an immiscible oil carrier phase. Because droplets can
be as small as femtolitre, they generally contain small amounts of
template DNA molecules or even none, so recombination between
homologous or partially homologous gene fragments during PCR
process can be prevented. Consequently, the synthesis of short,
chimeric products and other artifacts are avoided [14,17]. There-
fore, PCR in droplets has promising applications in single-cell and
single-molecule analyses, with the nucleic acids from one cell
being ampliﬁed inside one droplet. Indeed, single-molecule reso-
lution has been demonstrated in an on-chip well-based PCR de-
vice [22]. An additional beneﬁt of the droplet based PCR is that
multiplex assay will be more conveniently acquired in droplets.
For example, Zhong et al. [23] demonstrated multiplexing real-
time PCR in droplets to overcome multiplexing limit caused by
the spectral overlap of the ﬂuorophores in real-time PCR. The
droplet-based PCR can also achieve high-throughput screening of
transcription factor targets, ideal for exploration of genomic and
cDNA libraries [9,24e31]. This technology will therefore greatly
improve our understanding of disease pathophysiology and
diagnosis.
Currently, there are two main approaches to performing
microﬂuidic PCR in droplets: digital microﬂuidics e.g. Refs. [13,32],
and continuous-ﬂow microﬂuidics e.g. Ref. [7]. In contrast to
continuous-ﬂow microﬂuidics, one advantage of digital micro-
ﬂuidics is that most established chemistries and protocols can be
directly used in small droplets. It often uses electrowetting and
dielectrophoresis to generate droplets and manipulate their
dynamical behaviour such as splitting and merging, e.g. see Fig. 1. It
is convenient to automate the system with embedded electronic
circuits. For example, Hua et al. [33] presented an automated digital
microﬂuidic platform for multiplexed real-time PCR assays. A more
recent example is the integrated digital microﬂuidics CMOS real-
time PCR chip, which has the capability of real-time measure-
ment at single-molecule level [34]. Furthermore, digital micro-
ﬂuidic platform can be conﬁgured ﬂexibly and is not restricted to
usually ﬁxed PCR thermal cycles and inﬂexible dwell times often
associated with continuous-ﬂow systems. Until now, the digital
microﬂuidics approach has therefore been commonly-used for
performing microﬂuidic PCR in droplets [32,35,36]. However, dig-
ital microﬂuidics may be difﬁcult to produce and handle a signiﬁ-
cant number of droplets on-chip in a sequential order during a
short period of time, while the complementary continuous-ﬂow
approach has demonstrated its capability in this regard. For
example, the continuous-ﬂow microﬂuidic device developed by
Pekin et al. [37] is able to generate millions droplets on-chip with
well-mixed PCR mixture for quantitative and sensitive detection of
rare mutations. The focus of this paper will therefore be on
continuous-ﬂow PCR in droplets.
3. Continuous-ﬂow microﬂuidic PCR in droplets
Digital microﬂuidics usually performs its chemical and biolog-
ical functions in stationary or semi-stationary droplets. By contrary,
droplets are often in motion in continuous-ﬂow dropletmicroﬂuidics, which poses a challenge for precise ﬂow control,
droplet manipulation, and rapid detection. Consequently, this
approach has made less headway towards system integration and
automation than the digital microﬂuidics.
In comparison with the conventional continuous-ﬂow micro-
ﬂuidic PCR devices working with a single aqueous phase, not only
does the continuouseﬂow microﬂuidic PCR in droplets lead to an
efﬁcient PCR but also eliminates the PCR inhibition and carryover
contamination. The thermal mass is further reduced while the
thermal cycles are shortened. Because the volume of droplets can
be as small as femtolitre, and PCR mixtures are conﬁned in small
droplets, any temperature change will be achieved uniformly. As
PCR mixtures are now contained in droplets, they have the same
dwell times, can thus be detected and subsequently sorted on chip
conveniently. So PCR function may be more readily integrated into
a highly automated lab-on-a-chip system. Each droplet containing
samples and reagents usually moves through the designed micro-
ﬂuidic networks in a strict order, so that chemical and thermal
conditions are reproducible for droplets. The repeatable equal
conditions for interactions of all droplets with their environment
contribute to an excellent stability of reaction conditions and
ensure highest reproducibility, leading to homogeneous processes
and products.3.1. Off-chip thermocycling
For continuous-ﬂow droplet-based microﬂuidic PCR, two types
of thermocycling have been used: on-chip and off-chip. Off-chip
thermal cycling is easy and efﬁcient to deal with a large number of
droplets simultaneously. For example, Eastburn et al. [38] reported
a novel droplet microﬂuidic device which can perform ~50,000
single-cell reverse transcription PCR (RT-PCR) reactions in a single
experiment to identify speciﬁc cells from a mixed human cell
population, using cell type-speciﬁc staining and TaqMan RT-PCR
probes. This work shows that droplet-based microﬂuidic system
can signiﬁcantly reduce labour, material consumption, and can
dramatically increase throughput for characterising large, hetero-
geneous populations of cells at the transcriptional level.
Recently, Yang and his colleagues reported an innovative
method of performing PCR in droplets [39]. The usual PCR thermal
cycles were performed in agarose droplets, and the droplets were
then cooled down to a temperature below 16 C, so they became
solid to make the follow-on analyses convenient [39]. This unique
feature is also useful to maintain the monoclonality of each droplet
for single copy genetic studies. Their droplet-based microﬂuidic
platformwas later reﬁned and applied to single-cell analysis of rare
pathogens, efﬁcient RNA/cell encapsulation and RT-PCR at a single-
cell level, and efﬁcient screening of afﬁnity ligands (aptamers) from
a complex single-stranded DNA library [9,40,41]. With the multi-
plex single-cell PCR capability, their platform provides a way for
ultra-high throughput and multi-parameter generic analysis of a
large population of cells to reveal stochastic variation in biological
systems.
However, in the above works, PCR thermal-cycling is performed
off-chip which may become a concern for further system automa-
tion, which is important for future microﬂuidic technology to
evolve out of laboratories and to be used by non-experts. In addi-
tion, labelling of individual droplets can be difﬁcult during and after
this off-chip thermal-cycling process, which is essential for system
automation to deal with many individual droplets containing
different PCR mixtures. Therefore, we will then discuss the most
important and exciting recent developments in continuous-ﬂow
microﬂuidic PCR in droplets with on-chip thermocycling.
Fig. 1. An example of handling femtolitre droplets using digital microﬂuidics approach [13]. Reproduced from Ref. [13] with permission from The Royal Society of Chemistry.
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thermocycling
Before microdroplet technology was introduced for droplet-
based microﬂuidic PCR, immiscible liquids had been used to
isolate the sample slugs from each other tomitigate some problems
associated with single-phase ﬂow PCR i.e. carryover contamination
between successive samples, particle adsorption at the surface, and
diffusional dilution of samples [42]. For example, Curcio and
Roeraade [43] injected the samples/reagents in separate aqueous
segments isolated by an immiscible organic liquid as the contin-
uous ﬂow phase. However, an intermediate cleaning process be-
tween two consecutive samples was needed to reduce carryover
contamination between samples. Similarly, others also used a
second phase ﬂow to prevent sample contamination by separating
the aqueous sample ﬂows [44e46]. Another plug-based micro-
ﬂuidic device was demonstrated by Boedicker at al. [47], improved
on the earlier work of Song, Rice and Ismagilov [48], which was a
sophisticated example of integration of the droplet reactor device.
To avoid PCR inhibition, it is important to prevent the direct
interaction between PCR mixtures and device surfaces. However,
the use of plugs/segments does not eliminate the adsorption
problem even with a surface treatment [44]. Therefore early
droplet-based microﬂuidic PCR devices emerged to tackle the
contamination problem.3.2.1. Continuous-ﬂow microﬂuidic PCR in droplets
Nisisako, Torii and Higuchi [49] started to inject the aqueous
phase into an immiscible oil phase to form droplets, where each
droplet represents a transportable individual reaction volume
which does not interact with its surrounding medium. This led to
early droplet-based microﬂuidic PCR devices in which capillary
tubes were often used. For example, Dorfman et al. [50] used 4.5-
m-long PEA capillary with internal diameter of 800 mm, coiled
around a cylinder, and performed 35 thermal cycles while the PCR
mixture was encapsulated in 1 mL droplets. A similar design ofthermal cycles appeared more recently [51]. Hartung et al. [52]
generated droplets within Teﬂon FEP tube and T-connectors, and
integrated continuous reverse-transcription process, where the
viruses were detected in very low concentration. Markey, Mohr and
Day [53] also used T-junction to generate droplets, which was
attached to PTFE tubing. The DNA ampliﬁcation occurred in the
PTFE tubing, which was coiled around the aluminium cylinder
heaters. There were some different layouts of the devices reported
in the literature. For example, Gonzalez et al. [54] presented a ro-
tary PCR device and demonstrated robust detection of the low-copy
transcript CLIC5 from 18 cells per microliter in cultured lympho-
blasts. A closed-loop parallel-ﬂow device was also reported [55].
An interesting approach to accomplish thermal cycles, very
different from the above works, was reported by Ohashi et al. [56],
in which the authors used the external magnet to drive aqueous
droplets containing hydrophilic magnetic beads through different
temperature zones in a ﬂat-bottomed tray-type reaction chamber.
Similarly, Okochi et al. [57] used magnetic force to control droplet
motion in performing RT-PCR.3.2.2. On-chip integration
Meanwhile, on-chip system integration of droplet-based
continuous-ﬂow microﬂuidic PCR started to emerge [58e61].
Mohr et al. [58,59] successfully developed and tested such a device,
see Fig. 2. Their chip was mill-machined on a polycarbonate sheet,
sealed with a 100 mm thick acetate foil. The number of thermal
cycles was ﬁxed at 32 and each cycle was 63 mm long. The di-
mensions of the overall device were 75 mm  74 mm  4 mm, and
the droplets were generated in a T-junction with a uniform volume
of 51 nL approximately. With an optical monitoring system, this
device was able to perform quantitative real-time PCR measure-
ments. The operation ﬂow rates and temperature control were
optimised by computational ﬂuid dynamics simulations. A 60-base
pairs fragment from the RNase P gene was successfully ampliﬁed.
Beer et al. [60,61] reduced the droplet size to picolitre and
developed real-time measurement capability using ﬂuorescence
Fig. 2. (a) The continuous-ﬂow droplet-based microﬂuidic PCR. (b) Layout of the PCR chip. Reproduced from Ref. [59] with permission of Springer.
Fig. 3. The schematic diagram of the radial PCR device from Ref [66], where the inlet A
is for oil injection and inlets B1 and B2 are for aqueous phase injection, and the
droplets are generated at the T-junction C. The hot zone D is for denaturation, and the
periphery E is for primer annealing and template extension. The ﬁnal product after 34
thermal cycles is collected at the exit F. Reprinted with permission from Ref. [66].
Copyright {2009} American Chemical Society.
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advantages of using aqueous droplets and immiscible oil-phase as
the carrier ﬂuid. This silicon based device has an off-chip valving
system, which traps, stops and shunts the PCR mixture to perform
thermal cycles within the microchannels. This platform requires
only 18 thermal cycles for single-copy real-time detection, using
Taqman-based FRET probes. It was used for RT-PCR to amplify cDNA
from a complimentary RNA template. This work shows that droplet
microﬂuidics provides a powerful tool for ampliﬁcation of single-
copy target nucleic acids from a complex environment. However,
it is awell-based continuous-ﬂow PCR devicewhere thewhole chip
and ﬂuids need to be heated up and cooled down for each thermal
cycle. Therefore, the large thermal mass causes lengthy PCR pro-
cess. This droplet microﬂuidic platform was later used for single
transposition reactions [62]. Meanwhile, on-chip well-based PCR
device can perform PCR thermocycling for many droplets simul-
taneously, which is particularly suitable for ampliﬁcation of a large
number of samples. For example, Bian et al. [22] reported the
simultaneous and sensitive detection of pathogenic Escherichia coli
O157 and Listeria monocytogenes with such a device. Wang et al.
[63] compared the same device with the conventional quantitative
real-time PCR and demonstrated its superior performance for its
sensitive and efﬁcient detection of lung cancer-related genes. Tao
et al. [64] developed a similar device to amplify and sequence single
recombinant viruses with high ﬁdelity in picoliter droplets.
To enhance throughput, Kiss et al. [65] developed a continuous-
ﬂow microﬂuidic PCR device with a capability of generating mil-
lions of uniform droplets per hour, which was able to amplify 245-
base pairs adenovirus product in droplets within 35 min at the
starting template concentrations as lowas 1 templatemolecule/167
droplets. In this device, a ﬂuorescence monitoring systemwas used
to collect data for the real-time measurements. Later, a very
different radial design of continuous-ﬂow PCR chip was reported by
Schaerli et al. [66], which was used to amplify 85-base pairs of DNA
in 17 min within 34 thermal cycles as shown in Fig. 3. The tem-
perature gradient of the droplets were monitored and measured by
adding ﬂuorescence (rhodamine B) lifetime imaging to the aqueous
PCR mixture. Wang and Burns [67] fabricated a glass-silicon chip to
investigate the critical reagent concentration, which showed no
volume loss of the droplets carrying PCR mixture even after 40
thermal cycles. The device was further reﬁned to perform a two-
step PCR with on-chip droplet generation, merging and mixing
[68]. However, the generated droplets were relative large with
volume of around 200 nL, so mixing by diffusion alone took about
10 min. Different mixing methods were therefore studied to
expedite diffusion process to reduce mixing time to less than 1 s. A
two-step thermal cycled bio-reaction - nest TaqMan PCR - was
eventually successfully demonstrated, which was faster and moresensitive than the regular one.
In order to develop an integrated platform to perform cell lysis,
bio-reaction and PCR ampliﬁcation on chip, magnetic force was
exploited for droplet manipulation [59]. In this work, the magnetic
beads were added in the droplets in addition to the cell samples so
that the droplet dynamic behaviour may be manipulated through
the magnetic force acting on the droplets by an applied external
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genes were completed on-chip. As the applied force on droplet can
be externally controlled, it provides additional ﬂexibility in
manipulation of droplets, which is essential for system automation
and integration. Indeed such a highly automated continuous-ﬂow
PCR device was developed for real-time quantitative PCR in drop-
lets [51]. The system architecture design can be found in Fig. 4,
where a ‘conveyor belt’ concept was introduced to perform high-
throughput PCR with the droplets containing PCR mixtures mov-
ing through a tubing coiled around the heaters continuously.
To reduce PCR thermocycling time and to enable rapid RT-PCR in
droplets, wire-guide droplet manipulation technique was attemp-
ted in a continuous-ﬂow system [69]. With the aid of computa-
tional ﬂuid dynamics simulations, the authors found the optimal
operating conditions and achieved 1e4 s for a 10 mL droplet to
complete each temperature changes leading to signiﬁcant reduc-
tion of process times. Further time saving is expected if smaller
droplets are to be used. The platform, which was simple and
convenient to operate, was demonstrated by ampliﬁcation of 160-
base pairs gene sequence from 2009H1N1 inﬂuenza A. The total
PCR process for 30 thermo-cycles took 510 s with 4 additional
minutes for reverse transcription.
Different designs for on-chip thermal cycles have been tested as
well. Oscillatory thermal cycling, which may reduce chip footprint
and make microﬂuidic channel networks less complex in a
continuous-ﬂow microﬂuidic platform, was used for the ﬁrst
Nested-PCR for tyrosinase gene detection on chip as shown in Fig. 5
[70]. Bidirectional ﬂow was also adopted to make thermo-cycling
easy to implement in an interesting centrifugal microﬂuidic de-
vice for RT-PCR in droplets [71], where centrifugal forcewas used as
driving power, exploiting density difference of the water and oil
phases for droplet manipulation. The recent development of
continuous-ﬂow microﬂuidic devices that perform on-chip PCR in
droplets is summarised in Table 1.3.3. Optoﬂuidics: droplet heating and manipulation
Instead of microheaters, the optoﬂuidic heating method can
provide additional ﬂexibility for device conﬁguration, thermocy-
cling number and dwell times, which is essential for system inte-
gration and automation. It offers an alternativeway to heat droplets
as it can provide localised heat. For example, Kim et al. [72]Fig. 4. The illustration of system architecture of the continuous-ﬂow PCR device [51].reported to use laser light to heat nanodroplets for real-time PCR,
where the laser light provides not only the localised heating, but
also temperature measurement and Taqman real-time readout in
nanoliter droplets on a disposable plastic substrate. The selective
heating scheme using an infrared laser appears ideal for PCR
because it heats droplets only, resulting in fast thermal response.
The authors reported to complete 40 cycles of PCR in just 370 s. No
microheaters or microﬂuidic circuitry were deposited on the sub-
strate, and PCR was performed in one droplet without affecting
neighbouring droplets. This optoﬂuidic technique was later
extended to control droplet temperature for thermocycling [73].
In addition to providing localised heat, optoﬂuidic heating
method can also be used to manipulate droplet dynamical behav-
iour. The localised laser light heating generates a temperature
gradient along the droplet interface, which leads to a thermoca-
pillary force. This induced force is sufﬁciently large to actively
manipulate droplet motion [74]. Therefore, optoﬂuidic techniques
may become a practical and convenient tool for ﬂexible thermo-
cycling and active manipulation of droplets, which may play a
key role in an integrated and automated droplet-based microﬂuidic
system.3.4. Single-molecule and single-cell PCR
Since PCR process is able to generate millions of copies of a
particular DNA sequence from a single copy, it has become themost
promising tool for single-molecule analysis [75]. However, the
standard PCR is difﬁcult to be used for single-molecule analysis as it
suffers from preference of amplifying short fragments and pro-
ducing short chimeric molecules. By contrast, droplets have a
dramatically reduced reaction volume ranging from femtolitre to
nanolitre, so each droplet contains a small amount of template DNA
molecules or even none of them. Meanwhile, a single template
molecule in a droplet is able to produce saturating concentration of
PCR product after a limited number of thermo-cycles, which can
enhance ﬂuorescence detection. For example, Leman et al. [13]
showed that femtolitre droplets can be generated and manipu-
lated on-chip, and demonstrated single-molecule ampliﬁcation of
129-base pairs PCR product in 20 fL droplets. Small droplets thus
provide an ideal environment for single-molecule analysis, which
was one of the main driving forces underpinning droplet-based
microﬂuidic PCR from the very beginning [22,39,41,61e64,66].Reproduced from Ref. [51] with permission from The Royal Society of Chemistry.
Fig. 5. The design of oscillatory thermal cycling from where the droplet moves through denaturation (a and d), annealing (b and e), and extension (c and f) regions. (g) Gel analysis
of nested-PCR results for tyrosinase gene. The details can be found in Ref. [70]. Reprinted from Ref. [70], Copyright (2011), with permission from Elsevier.
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Although signiﬁcant advances have been made in developing
droplet-based continuous-ﬂow microﬂuidic PCR devices, most of
them were still focused on single PCR function. An ideal micro-
ﬂuidic system with implemented on-chip PCR function should be
fully autonomous, easy for non-experts to use, and has complete
protocol integration from sample collection to ﬁnal analysis [76].
Ultimately, future droplet-based microﬂuidic system may be
intelligent enough to perform autonomous scientiﬁc discovery it-
self [77].
To automate droplet-basedmicroﬂuidic processes including PCR
function on chip, three key steps are required to perform on-chip
seamlessly, i.e. sample preparation (e.g. cell capturing, sorting,
culturing, lysis, toxicity screening), thermo-cycling, and subsequent
operations (e.g. detecting the concentration of intermediate prod-
uct, hybridisation of the ampliﬁed DNA sequences). At present,
these steps are often separate andmay be off-chip as well. Although
automated microﬂuidic PCR devices have been reported, where the
PCR processes were not performed in droplets [78e80], progress
towards an automated, sample-in& answer-out, and droplet-based
continuous-ﬂow microﬂuidic system has been slow due to the
daunting research challenges associated with system design and
operation.
4.1. Research challenges
One of these research challenges is that fast detection methodsTable 1
Continuous-ﬂow microﬂuidic systems with on-chip PCR in droplets.
Year References Features
2006 Mohr et al. [57], and later Mohr et al. [58] On-chip droplet generation; on-line m
out to optimise the design and opera
2007 Beer et al. [59], and later Beer et al. [60] &
Heredia et al. [61]
Well-based; on-chip droplet generati
2008 Kiss et al. [62] On-chip droplet generation at a rate o
ﬂuorescence detection within each d
2009 Schaerli et al. [63] The temperatures of droplets were me
droplet generation and manipulation
Wang et al. [64], and later Wang et al. [65] On-chip droplet generation, merging
2011 You et al. [66] Wire-guide droplet manipulation; nu
Sciancalepore et al. [67] Oscillatory thermal cycling
2013 Wang et al. [68] Centrifugal microﬂuidic device; wirel
2015 Bian et al. [22], Wang et al. [63] Well-based; on-chip droplet generati
Tao et al. [64] Well-based; on-chip droplet generatiare required to probe small volume droplets dynamically. Advances
in single-molecule detection [81], ﬂuorescence lifetime imaging
[82], spectroscopy [83] could be used to interrogate droplets.
However, this is out of scope of this review. More information about
detection methods can be found in recent review papers e.g.
Ref. [84].
Another major challenge is to control droplets' dynamical
behaviour on-chip to realise their desired functions. In a droplet
microﬂuidic system, each droplet usually moves through the
designed microﬂuidic networks in a strictly pre-determined order,
so that chemical and thermal conditions are reproducible for each
droplet, leading to homogeneous processes and products. But this
poses a research challenge to appropriately design a hierarchy of
complex microﬂuidic channel network to achieve desired integra-
tion and automation, which requires precise control of individual
droplets including generation on-demand, transport, splitting,
merging and storage, although some ﬂexibility can be introduced
by using additional optical and/or electronic components for active
droplet manipulation [32,77]. The commonly-used mechanical
components including valves and pumps may be used to control
ﬂow on-chip and manipulate droplets. However, these moving
components are difﬁcult and expensive to fabricate and implement
on-chip, and they are certainly becoming a major concern for
robustness of the microﬂuidic systems. A new way of ﬂow control
on-chip without (or with minimal) moving parts is required to
enable system integration and automation. Recently emerged
concept of droplet intelligence/computingmay be exploited for this
purpose.onitoring of ﬂuorescence level within each droplet; numerical simulations carried
tion conditions.
on; off-chip valve for ﬂow control; on-line ﬂuorescence detection
f millions droplets per hour; on-chip sample injection and manipulation; on-line
roplet; single-molecule PCR.
asured by ﬂuorescence lifetime imaging inside the droplets; radial layout; on-chip
; on-line ﬂuorescence detection within each droplet
and mixing; no volume loss of droplets after 40 thermal cycles
merical simulations carried out to ﬁnd optimised operating conditions
ess temperature control; online ﬂuorescence detection
on
on, detection and sorting
Y. Zhang, H.-R. Jiang / Analytica Chimica Acta 914 (2016) 7e16144.2. Droplet intelligence/computing
Analogous to integrated electronic circuits, integrated micro-
ﬂuidic circuits (IMCs) utilise principles such as ﬂuidic resistance
and networks of microvalves to design computing functions, e.g.,
logic gates, counters, oscillator, timers [85]. Meanwhile, droplet-
based microﬂuidics can also take advantage of the discrete nature
of the droplets to enable more ﬂexible devices for complex bio-
logical/chemical analysis. In this case a droplet represents a single
“bit” of information as well as acting as a discrete chemical reactor.
The size of droplets and their ﬂow patterns may provide an addi-
tional basis for computing functions. So far, microﬂuidic devices
have demonstrated simple logic operations, including AND, OR,
NOT, NOR, NAND, and XNOR [86,87]. Droplet ﬂows in microﬂuidic
channel networks are able to encrypt and decrypt signals coded in
the intervals between droplets [88]. Using microﬂuidic logic gates
to convert a series of input signals into a parallel set of control
actions has also been reported [89].
The microﬂuidic computing capabilities may be directly com-
binedwith biological and chemical functions in the same devices to
design and guide autonomous experiments, free of (or with mini-
mal) human intervention. Simple individual microﬂuidic
computing functions have been reported in the literature but
integration of these functions to achieve comprehensive ﬂow
control and communications between droplets, still needs imagi-
nation and ingenuity. Every implementation of droplet computing
functions is bespoke, in contrast to equivalent Boolean circuits, and
depends on collective dynamical behaviour of the droplets. How-
ever, the nonlinear dynamical behaviour of droplets is often non-
intuitive and difﬁcult to predict, so a rational design simulation
tool is required to enable system design (to be discussed in Section
4.3).
To achieve combined computing and biological/chemical func-
tions, multi-layer 3D structural hierarchies in microﬂuidic net-
works may be exploited with one layer for ﬂow control and
communication using droplet intelligence/computing functions
and another layer for performing chemical/biological reactions in
droplets. The individual droplets may be labelled so that they are
not restricted to spatial order, which is easy for identiﬁcation of
droplets but complex to implement on-chip as an additional
labelling and recognitionmodule is required. Pre-determined order
at the design stage or dynamically determined by droplet intelli-
gence control will be complementary to labelling of every droplet.
With necessary and appropriately integrated micro-electronic/
optical sensors and actuators, microﬂuidic device combined with
a droplet intelligence would be smart, self-regulating, and able to
make logical decisions based on the experimental results in order
to generate subsequent experiments. The device can be best used
for optimising and creating enzymes, drug screening, complex
protocol sequences, and optimisation of PCR conditions.
4.3. Virtual design and experiment platform
In developing highly automated and integrated systems, the
major challenge is to monitor and control the biological and
chemical processes in droplets in order to rapidly acquire infor-
mation to make decisions for the follow-on experiments. These
systems need to combine the additional reactions and preparation
steps in the same device [90]. The complexity of integrated
microﬂuidic processes, in addition to the often non-intuitive ﬂow
physics, makes system integration and automation even more
difﬁcult. A novel design simulation tool is urgently required to
enable future automated and integrated microﬂuidic systems.
The present trial and error approach may work for demon-
strating the concept of individual microﬂuidic components, butbecomes increasingly inappropriate for designing complex auto-
mated and integrated systems. Simply mimicking conventional and
current systems at the macroscale may fail as ﬂow physics and
chemistry can be very different at the micro-scale. Even worse, the
scaled-down microﬂuidic devices are often difﬁcult and expensive
to make due to a complex device structure involving many moving
components. Therefore, we need to supplant the presently domi-
nant empirical approaches e i.e. trial and error, and mimicking
conventional systems e with a more strategic methodology based
on state-of-the-art knowledge and techniques from across disci-
plinary boundaries. The resulting virtual design and experiment
platform (VDEP) will be able to simulate and visualise how the
chemical and biological processes behave inmicroﬂuidic devices, to
facilitate the design of integrated systems to realise automated
processing, optimise output, and to minimise the risk of runaway
and other hazards. VDEP will predict the operational success of bio/
chemical processing within a simulated virtual environment before
the system is fabricated and tested. Not only does this expedite the
system development cycle, but also will be able to achieve what is
currently impossible for empirical approaches. It is the key to
designing complex IMCs to achieve droplet intelligence/computing
functions through simulation and visualisation of droplets' dy-
namic behaviour in complexmicrochannel networks. Development
of such design simulation tool requires consorted effort from
computational ﬂuid dynamics, chemistry, biology, physics, soft-
ware engineering, and high-performance computing. However,
VDEP may enable future autonomous scientiﬁc discovery by
exploiting microﬂuidic microdroplet technologies.
5. Future: smart microﬂuidic platforms for autonomous
scientiﬁc discovery
Future smart microﬂuidic platform will have a major impact on
artiﬁcial intelligence and biological computations. It is ideal for
applications, e.g. directed evolution and closed loop synthesis,
which need to react to feedback by redirecting the experiment. To
conclude this paper, we will speculate an example of future smart
droplet-based microﬂuidic platform for autonomous scientiﬁc
discovery: evolutionary algorithms to achieve automated discovery
of anti-inﬂammatory small-molecule combinations using an
intelligent microﬂuidic device as illustrated in Fig. 6.
Recently, Small et al. [91] reported conventional multiple-
objective evolutionary computing to design experiments to screen
optimal compound combinations out of 33 compounds, targeting to
inhibit signalling pathways leading to IL-1b cytokine (a potent pro-
inﬂammatory protein) production. IL-1b activation pathways in im-
mune macrophage cells are well-deﬁned. Lipopolysaccharide (LPS),
the major component of the outer membrane of Gram-negative
bacteria, binds to Toll-like receptor expressed by macrophages. This
will activate multiple proteins in the signalling networks, leading to
IL-1b production. Targeting these proteins provides an effective
pharmacological modulation to IL-1b production and may lead to
therapy for IL-1b mediated inﬂammatory diseases. To search for
optimal reagent combinations in modulating IL-1b signalling path-
ways from a dynamical chemical library of 33 compounds, the po-
tential search space is about 9 billion. With an evolutionary
computing strategy, the satisﬁed solutions were obtained with only
550 combinations, i.e. 550 rather than 9 billion experiments [91].
Evolutionary computing can be designed as a physical process in
a microﬂuidic device, combined with its biological and chemical
functions, which can efﬁciently search for these optimal compound
combinations. This autonomous drug discovery process may
include seven experimental steps in four modules as illustrated in
Fig. 6. IMCs need to be created for logic operations in Module A to
realise pair-wise combinations in each droplet for each generation
Fig. 6. The automated drug discovery microsystem. The experimental steps are: S1: A
series of pair-wise combinations of the selected compounds with the same volume will
be injected into uniform droplets sequentially, and the droplet generation order and its
compounds will be recorded; S2: Each droplet will then be delivered in order to
receive the same volume of macrophage cells, ensuring a uniform cell concentration in
each droplet; S3: An incubation step (effect of compounds on macrophage cells) will
occur for the droplets in Module B1 for a speciﬁc time, and the droplets will leave the
on-chip incubator in the same sequential order; S4: LPS will then be injected into these
droplets to activate macrophage cells; S5: Again, an incubation step is required in
Module B2 before real-time RT-PCR starts; S6: PCR will quantify the production of IL-
1b mRNA in each droplet and provide ﬁtness information to Module D (a compound
combination with greater ﬁtness, i.e. a lower level of IL-1b mRNA, has better chance to
be selected); S7: Consider sharing of individual compounds in all the droplets to re-
compute the ﬁtness levels. An appropriate strategy, such as truncation selection
[92], will be used to select the best compound combinations, and to generate the next
generation compound combinations in S1 with an appropriate reproduction strategy
such as the elitism and random combinations; S1eS7: the cycle will be repeated until
an acceptable solution is found. For a small number of surviving compounds, say 5,
pair-wise screening will then be performed together with a dose sensitivity study to
obtain the optimal compound combination, which can be compared with conventional
experimental results. Module A: to generate droplets in sequential order (each
containing one combination of compounds), and to deliver them to receive macro-
phage cells ; Modules B1 & B2: cell incubation; Module C: real-time RT-PCR for
quantiﬁcation of IL-1b mRNA expression in each droplet i.e. ﬁtness of the com-
pound combination in each droplet, and represents the droplets containing the
PCR Mastermix (one-step real-time RT-PCR reagents); Module D: to process the
droplet generation information from Module A together with the ﬁtness information
from Module C to select compounds and recombine them, so Module A will be acti-
vated to form the new combinations for the next generation of experiments.
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compounds. A timer circuit will be designed for cell incubation
steps in Modules B1 & B2. The PCR module will have embedded
micro-optical and micro-electronic components that detect ﬂuo-
rescence level in each thermal cycle to quantify IL-1b mRNA pro-
duction and transfer information to Module D. Module D is the
“brain” of this device, using complex IMCs to convert the electric
signals for IL-1b mRNA production from the PCR module. Together
with the droplets/compounds information from Module A, it
recalculates the ﬁtness of each droplet containing a combination of
compounds to preserve diversity. In addition, it realises appropriate
selection and reproduction strategies to generate the next gener-
ation of compound combinations through Module A, where inte-
grated microelectronic components will be used as actuators and
provide motive power. This example for automated drug discovery
illustrates the potential of microﬂuidic microdroplet technology for
future autonomous scientiﬁc discovery.6. Conclusions
Continuous-ﬂow droplet-based microﬂuidic PCR has madeheadway at individual component level, and has demonstrated its
great potential for high-throughput, single-cell and single-
molecule analyses. However, highly integrated systems including
pre and post PCR processes and other bio/chemical functions are
still rare. Automation of integrated systems is even more chal-
lenging to develop. Emerging droplet intelligence/computing
functions may provide a new way of achieving on-chip control of
droplet dynamical behaviour to enable system automation. To
design such intelligent automated and integrated systems, a
powerful virtual design and experiment platform is required to
supplant the present empirical design methodologies.
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